Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Applied Therapeutics Inc (NASDAQ: APLT) was $0.48 for the day, down -5.70% from the previous closing price of $0.51. In other words, the price has decreased by -$5.70 from its previous closing price. On the day, 1.43 million shares were traded. APLT stock price reached its highest trading level at $0.509 during the session, while it also had its lowest trading level at $0.4581.
Ratios:
Our analysis of APLT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.00 and its Current Ratio is at 3.00. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On December 02, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $13 to $2.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 29, 2024, whereas the target price for the stock was revised from $12 to $4.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’25 when Perfetti Riccardo sold 10,366 shares for $0.44 per share. The transaction valued at 4,561 led to the insider holds 890,409 shares of the business.
Funtleyder Leslie D. sold 14,502 shares of APLT for $6,381 on Mar 04 ’25. The insider now owns 390,459 shares after completing the transaction at $0.44 per share. On Mar 04 ’25, another insider, Chinoporos Constantine, who serves as the insider of the company, sold 447 shares for $0.44 each. As a result, the insider received 197 and left with 271,436 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 67956480 and an Enterprise Value of 19894252. For the stock, the TTM Price-to-Sale (P/S) ratio is 251.70 while its Price-to-Book (P/B) ratio in mrq is 1.85. Its current Enterprise Value per Revenue stands at 75.073 whereas that against EBITDA is -0.183.
Stock Price History:
The Beta on a monthly basis for APLT is 2.00, which has changed by -0.9047619 over the last 52 weeks, in comparison to a change of 0.16932249 over the same period for the S&P500. Over the past 52 weeks, APLT has reached a high of $10.62, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is 20.97%, while the 200-Day Moving Average is calculated to be -77.97%.
Shares Statistics:
APLT traded an average of 2.24M shares per day over the past three months and 1587410 shares per day over the past ten days. A total of 141.58M shares are outstanding, with a floating share count of 116.52M. Insiders hold about 17.70% of the company’s shares, while institutions hold 74.82% stake in the company. Shares short for APLT as of 1752537600 were 13246500 with a Short Ratio of 5.92, compared to 1749772800 on 21327659. Therefore, it implies a Short% of Shares Outstanding of 13246500 and a Short% of Float of 9.42.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 3.0 analysts. The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.09 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.46 and -$0.66 for the fiscal current year, implying an average EPS of -$0.59. EPS for the following year is -$0.54, with 3.0 analysts recommending between -$0.26 and -$0.71.
